C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Name: C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)
SKU: 3345
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 35 No. 2 Articles Tags: c-lindsay-devane, cytochrome-p-450, drug-interactions, heidi-l-liston, john-s-markowitz, medworks-media, nefazodone, pharmacokinetics, psychopharmacology-bulletin, s-craig-risch, ssri, venlafaxine

Description

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

C. Lindsay DeVane, PharmD, John S. Markowitz, PharmD, Heidi L. Liston, PharmD, and S. Craig Risch, MD

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Paliperidone Double-blind, Placebo- and Active-Controlled, Study

C. Lindsay DeVane, PharmD: Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

Description

C. Lindsay DeVane, PharmD

DRUG INTERACTIONS

Charleston Antidepressant Drug Interactions Surveillance Program (CADISP)

C. Lindsay DeVane, PharmD, John S. Markowitz, PharmD, Heidi L. Liston, PharmD, and S. Craig Risch, MD

Related products

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Test of Treatment in Psychiatric Practice by Feras Ali Mustafa

Monoarthritis Induced by Bupropion Hydrochloride by Barry N. Williams

Paliperidone Double-blind, Placebo- and Active-Controlled, Study